Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for the prescreening of drugs targeted to the V3 hypervariable loop of the HIV-1 envelope glycoprotein gp 120

Method for the prescreening of drugs targeted to the V3 hypervariable loop of the HIV-1 envelope glycoprotein gp 120

US Patent 5230998 · Granted Jul 27, 1993

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fusion protein and use thereof2025
Ketoamide compound and preparation method, pharmaceutical composition, and use t2024
Broad-spectrum polypeptide against enterovirus and application thereof2024
Immunogenic composition for MERS coronavirus infection2021
Immunopotentiator-linked oligomeric influenza immunogenic compositions2018
Immunogenic composition for MERS coronavirus infection2018
Stabilized trimeric HIV-1 GP41 fusion inhibitor polypeptides comprising the N-te2017
Influenza hemagglutinin-specific monoclonal antibodies for preventing and treati2017
Immunopotentiator-linked oligomeric influenza immunogenic compositions2017
Stabilized trimeric HIV-1 gp41 fusion polypeptides comprising the N-terminal hep2015
Immunoenhancer-linked oligomeric HIV envelope peptides2015
2-(4-substituted phenylamino) polysubstituted pyridine compounds as inhibitors o2015